RGMP — Regnum Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for Regnum, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0.021	0.006	0.009	0	0
Cost of Revenue
Gross Profit	—	—	0.007	0	0
Selling / General / Administrative Expenses
Depreciation and Amortization
Total Operating Expenses	0.018	0.042	0.127	0.368	0.736
Operating Profit	0.003	-0.036	-0.118	-0.368	-0.736
Other Net Non Operating Costs
Net Income Before Taxes	0.003	-0.036	-0.118	-0.27	-0.781
Provision for Income Taxes
Net Income After Taxes	0.002	-0.036	-0.118	-0.27	-0.781
Net Income Before Extraordinary Items
Net Income	0.002	-0.036	-0.118	-0.27	-0.781
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	0.002	-0.036	-0.118	-0.27	-0.781
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0	-0.002	-0.005	-0.012	-0.034
Dividends per Share